In the past, there was a long-standing concept of "emphasis on raw materials, light on excipients" in the development of China's pharmaceutical industry. With the revision of the Chinese Pharmacopoeia (2020 edition), the new version of the pharmacopoeia has put forward new standards and requirements for the development of pharmaceutical excipients, which has increased the attention of pharmaceutical excipients in the whole industry.

        As a basic material and an important part of pharmaceutical preparations, pharmaceutical excipients can account for more than 90% of drugs, not only can improve the stability of drugs, but also have important functions such as solubilization, excipients, solubilization, slow and controlled release, and act as carriers, etc. The quality of which is related to the quality, safety and effectiveness of drugs.

        As a high-tech enterprise focusing on the manufacture of pharmaceutical excipients "plant hollow capsules", our company is committed to providing high-quality plant hollow capsules for the global pharmaceutical industry.

        Recently, Xie Hongyuan, deputy director of Jiangsu Huai'an Airport Industrial Park Management Committee, visited our Hebei production base for a site visit. The annual production capacity of the base is 1.6 billion capsules, and the products are mainly sold to Europe and America. During the visit, Deputy Director Xie Hongyuan highly praised our company's technical innovation and market performance in the field of pharmaceutical excipients plant hollow capsules.

        Jiangsu is a large biomedical province, and the province's biomedical industry will achieve an output value of over 500 billion yuan in 2022, with a year-on-year growth of over 9%. Huai'an is located in the north-central part of Jiangsu Province, and is an "important central city in northern Jiangsu Province", attracting famous pharmaceutical companies such as Zhengzheng Pharmaceutical, Zhengda Tianqing and Tianjin Tianshili to settle in the park. Huai'an Airport Industrial Park covers an area of about 1,000 mu and focuses on the development of biopharmaceuticals, new materials and other leading industries.

        The visit was successfully concluded and both sides will further strengthen cooperation in the future to accelerate the promotion and application of the plant hollow capsule project and actively promote the upgrading of natural pharmaceutical excipients in the industry.